BioCentury
ARTICLE | Finance

Taiho’s new modality search engine

Taiho Ventures is deploying $300M to take its parent company’s pipeline beyond small molecules

May 29, 2020 11:27 PM UTC

With its parent company focused on small molecules for cancer, Taiho Ventures is using a recently upsized fund to find cutting edge modalities that take Taiho Pharmaceutical beyond its internal expertise.

President Sakae Asanuma established the corporate venture fund in 2016, after a four-year stint as president and CEO of Astellas Venture Management and U.S. head of Astellas Innovation Management. ...